Skip to main content
Premium Trial:

Request an Annual Quote

Mobidiag Inks South Africa Distribution Agreement

NEW YORK (GenomeWeb) – Mobidiag announced today that it has signed an agreement with PerkinElmer's Wallac Oy subsidiary to distribute its Amplidiag products in South Africa.

The agreement covers the firm's real-time PCR-based Amplidiag IVD gastrointestinal infection tests, such as the Amplidiag H. pylori+ClariR, Amplidiag Stool Parasites, Amplidiag CarbaR+VRE, Amplidiag C. difficile+027, and Amplidiag Bacterial GE, as well as the firm's high throughput Amplidiag Easy system.

Espoo, Finland-based Mobidiag previously signed distribution agreements in Sweden and Norway, Portugal, the UK, and other Eastern and Western European nations.

"Thanks to a large distribution network, our Amplidiag product line is now accessible in most European countries," Mobidiag CEO Tuomas Tenkanen said in a statement, adding, "Our ambition is now to expand our coverage worldwide and towards new markets."

Hanna Halme, PerkinElmer's vice-president for Europe, the Middle East, and Africa, noted that the firm continues to expand its "infectious disease offerings in regions such as Africa to help meet the health needs of these populations."

Mobidiag has also said it is developing a lower throughput platform called Novodiag as well as assays for gastrointestinal, respiratory, blood, skin, and central nervous system infections.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.